Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
37
pubmed:dateCreated
2011-9-14
pubmed:databankReference
pubmed:abstractText
The mammalian target of rapamycin (mTOR) is a central regulator of cell growth and proliferation in response to growth factor and nutrient signaling. Consequently, this kinase is implicated in metabolic diseases including cancer and diabetes, so there is great interest in understanding the complete spectrum of mTOR-regulated networks. mTOR exists in two functionally distinct complexes, mTORC1 and mTORC2, and whereas the natural product rapamycin inhibits only a subset of mTORC1 functions, recently developed ATP-competitive mTOR inhibitors have revealed new roles for both complexes. A number of studies have highlighted mTORC1 as a regulator of lipid homeostasis. We show that the ATP-competitive inhibitor PP242, but not rapamycin, significantly down-regulates cholesterol biosynthesis genes in a 4E-BP1-dependent manner in NIH 3T3 cells, whereas S6 kinase 1 is the dominant regulator in hepatocellular carcinoma cells. To identify other rapamycin-resistant transcriptional outputs of mTOR, we compared the expression profiles of NIH 3T3 cells treated with rapamycin versus PP242. PP242 caused 1,666 genes to be differentially expressed whereas rapamycin affected only 88 genes. Our analysis provides a genomewide view of the transcriptional outputs of mTOR signaling that are insensitive to rapamycin.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Eif4ebp1 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, 70-kDa, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/Sterol Regulatory Element Binding..., http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/mTORC1 complex, mouse, http://linkedlifedata.com/resource/pubmed/chemical/ribosomal protein S6 kinase, 70kD...
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
13
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15201-6
pubmed:meshHeading
pubmed-meshheading:21876130-Animals, pubmed-meshheading:21876130-Carcinoma, Hepatocellular, pubmed-meshheading:21876130-Carrier Proteins, pubmed-meshheading:21876130-Cell Line, Tumor, pubmed-meshheading:21876130-Cholesterol, pubmed-meshheading:21876130-Gene Expression Regulation, pubmed-meshheading:21876130-Gene Expression Regulation, Neoplastic, pubmed-meshheading:21876130-Liver Neoplasms, pubmed-meshheading:21876130-Mice, pubmed-meshheading:21876130-NIH 3T3 Cells, pubmed-meshheading:21876130-Phosphoproteins, pubmed-meshheading:21876130-Proteins, pubmed-meshheading:21876130-Ribosomal Protein S6 Kinases, 70-kDa, pubmed-meshheading:21876130-Sirolimus, pubmed-meshheading:21876130-Sterol Regulatory Element Binding Protein 2, pubmed-meshheading:21876130-TOR Serine-Threonine Kinases, pubmed-meshheading:21876130-Transcription, Genetic
pubmed:year
2011
pubmed:articleTitle
The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile.
pubmed:affiliation
Howard Hughes Medical Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural